Diffractive multifocal intraocular lens implantation in patients with monofocal intraocular lens in the contralateral eye
Author:
Corresponding Author:

Hungwon Tchah. Department of Ophthalmology, University of Ulsan College of Medicine, Asan Medical Center, #88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Republic of Korea. hwtchah@amc.seoul.kr

Affiliation:

Clc Number:

Fund Project:

Supported by the Student Research Grant of University of Ulsan College of Medicine, Seoul, Korea (No.17-18); Grant from the Asan Institute for Life Sciences, Seoul, Korea (No.2014-464).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    AIM: To evaluate clinical outcomes of unilateral implantation of a diffractive multifocal intraocular lens (IOL) in patients with contralateral monofocal IOL. METHODS: Twenty-two patients who already had implantation of a monofocal IOL in unilateral eye underwent implantation of a diffractive multifocal IOL in contralateral eye were enrolled. After 1, 6, and 12mo, uncorrected and distant corrected distant visual acuity (UCDVA and DCDVA), uncorrected and distant corrected intermediate-visual acuity (UCIVA and DCIVA), uncorrected and distant corrected near visual acuity (UCNVA and DCNVA), and contrast sensitivity were obtained. Halo/glare symptoms, spectacle dependence, and patient satisfaction were also evaluated. RESULTS: The mean age was 67.86±7.25y and the average interval between two IOL implantations was 645.82±878.44d. At 1mo, binocular UCDVA was lower than 0.20 logMAR in 76% of patients (mean 0.12±0.13 logMAR), which increased to 90% by 6 and 12mo. The binocular UCDVA was significantly better than the monocular results (P<0.05) at 1, 6, and 12mo. Additionally, UCNVA was lower than 0.40 logMAR in 82% of patients, increasing to 90% by 6 and 12mo. Mean UCNVA in the multifocal IOL implanted eye was statistically significantly better than that in the monofocal IOL implanted eye (P<0.05) at 1, 6, and 12mo. About 5% of patients at 1 and 6mo, reported “severe glare or halo”. Patient satisfaction rates were 95% and 91% at 6 and 12mo, respectively. CONCLUSION: Unilateral implantation of multifocal IOL in patients with a contralateral, monofocal IOL implantation results in high patient satisfaction rate, with low severe glare or halo rate during follow-up. It can represent a good option for patients who have previously had a monofocal IOL implantation regardless of two year interval duration between two IOL implantations.

    Reference
    Related
    Cited by
Get Citation

Jae Yong Kim, Yunhan Lee, Hun Jae Won, et al. Diffractive multifocal intraocular lens implantation in patients with monofocal intraocular lens in the contralateral eye. Int J Ophthalmol, 2020,13(5):737-743

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:March 24,2019
  • Revised:May 29,2020
  • Adopted:
  • Online: March 30,2020
  • Published: